Fentanyl and Nuclear magnetic resonance imaging abnormal - a phase IV clinical study of FDA data

Summary:

Nuclear magnetic resonance imaging abnormal is reported as a side effect among people who take Fentanyl (fentanyl citrate), especially for people who are female, 50-59 old, also take Fluconazole, and have Breast cancer.

The phase IV clinical study analyzes which people have Nuclear magnetic resonance imaging abnormal when taking Fentanyl. It is created by eHealthMe based on reports of 72,646 people who have side effects when taking Fentanyl from the FDA, and is updated regularly.

What is Fentanyl?

Fentanyl has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 73,301 Fentanyl users. Check the latest studies of Fentanyl.

What is Nuclear magnetic resonance imaging abnormal?

Nuclear magnetic resonance imaging abnormal is found to be associated with 469 drugs and 535 conditions by eHealthMe. Check the latest studies of Nuclear magnetic resonance imaging abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

72,646 people reported to have side effects when taking Fentanyl.
Among them, 78 people (0.11%) have Nuclear magnetic resonance imaging abnormal.

Could Fentanyl cause Nuclear magnetic resonance imaging abnormal?

Among these 78 people:

What is the gender of people who have Nuclear magnetic resonance imaging abnormal when taking Fentanyl? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Nuclear magnetic resonance imaging abnormal when taking Fentanyl? *

What are other drugs people take besides Fentanyl? *

Dexamethasone: 34 people, 43.59%
Zometa: 34 people, 43.59%
Fluconazole: 34 people, 43.59%
Neurontin: 32 people, 41.03%
Levaquin: 32 people, 41.03%
Citalopram Hydrobromide: 32 people, 41.03%
Metronidazole: 32 people, 41.03%
Nystatin: 32 people, 41.03%
Prednisone: 31 people, 39.74%
Clotrimazole: 31 people, 39.74%

What are other side effects people have besides Nuclear magnetic resonance imaging abnormal? *

Weakness: 53 people, 67.95%
Hypoaesthesia (reduced sense of touch or sensation): 48 people, 61.54%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 41 people, 52.56%
Dyspnea (difficult or laboured breathing): 41 people, 52.56%
Bone Disorder: 39 people, 50.00%
Urinary Tract Infection: 38 people, 48.72%
Pain In Extremity: 37 people, 47.44%
Tooth Abscess (pus formation in tooth): 37 people, 47.44%
Oedema Peripheral (superficial swelling): 37 people, 47.44%
Intervertebral Disc Protrusion (spinal disc protrusion): 36 people, 46.15%

What are the existing conditions these people have? *

Breast Cancer: 32 people, 41.03%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 23 people, 29.49%
Breast Cancer Metastatic: 22 people, 28.21%
High Blood Pressure: 12 people, 15.38%
Metastases To Bone (cancer spreads to bone): 11 people, 14.10%
Multiple Myeloma (cancer of the plasma cells): 9 people, 11.54%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 10.26%
Bone Pain: 8 people, 10.26%
Constipation: 8 people, 10.26%
Neuralgia (pain in one or more nerves): 5 people, 6.41%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl and have Nuclear magnetic resonance imaging abnormal?

- Check whether Nuclear magnetic resonance imaging abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fentanyl:

Fentanyl (73,301 reports)

Nuclear magnetic resonance imaging abnormal treatments and more:

Nuclear magnetic resonance imaging abnormal (5,432 reports)

How severe was Nuclear magnetic resonance imaging abnormal and when was it recovered:

Nuclear magnetic resonance imaging abnormal in Fentanyl

Expand to all the drugs that have ingredients of fentanyl citrate:

Nuclear magnetic resonance imaging abnormal and drugs with ingredients of fentanyl citrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nuclear magnetic resonance imaging abnormal:

Nuclear magnetic resonance imaging abnormal (469 drugs)

Browse all the conditions that are associated with Nuclear magnetic resonance imaging abnormal:

Nuclear magnetic resonance imaging abnormal (535 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate (the active ingredients of Fentanyl) and Fentanyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.